相关实验视频

Updated: Jun 6, 2025

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

Published on: January 29, 2021

来自固体瘤的勒普托门病的免疫疗法:目前的临床结果和未来的机会

Eleanor C Smith^1,2, Bryan T Mott^3,4, Emily Douglas⁵

¹Department of Cancer Biology, Wake Forest Baptist Medical Center, Winston-Salem, NC, USA. elesmith@wakehealth.edu.

Cancer metastasis reviews

|November 29, 2024

概括

免疫疗法对勒普托门病的疗效有限,勒普托门病是一种晚期癌症,在大脑和脊髓液中扩散. 对于开发有效治疗方法至关重要的是进一步研究勒普托门内尔免疫微环境.

科学领域:

神经瘤学神经瘤学
免疫学免疫学免疫学
在瘤学瘤学.

背景情况:

脑脊髓病 (LMD) 是转移性癌症的严重并发症,显著增加神经疾病和死亡率.
改进的全身癌症治疗已经导致瘤癌症的发病率增加,但预后仍然很差,没有确立的护理标准.
由于患者经常被排除在外,LMD的临床试验数据有限.

研究的目的:

审查免疫疗法在治疗来自固体瘤的勒普托门病的疗效.
讨论针对LMD的全身,内和联合免疫疗法方案.
为了突出进一步研究勒普托门性免疫微环境的需要.

主要方法:

综合性文献综述免疫疗法用于瘦骨关节疾病.
对全身和内治疗数据的分析.
检查正在进行的关于leptomeningeal免疫微环境的研究.

主要成果:

目前关于LMD免疫治疗的前性文献缺乏.
现有的免疫疗法对LMD的疗效似乎有限.
对于未来的治疗策略来说,了解勒普托门内尔免疫微环境至关重要.

结论:

进一步的前性研究是必不可少的,以得出关于LMD免疫疗法疗效的最终结论.
针对天生的免疫系统的新型免疫疗法显示出潜力.
为了优化LMD治疗,需要继续对乳腺内微环境进行研究.

关键词:

免疫微环境是一个微环境.免疫治疗是一种免疫疗法.导管内治疗治疗导管内治疗门关节疾病门关节疾病固体瘤是一种固体瘤.

更多相关视频

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...